Flotek Industries
Flotek Industries' revenue rose 26.9% to $237 million in fiscal 2025. Its operating margin was 9.8%, up from 6.5% a year earlier. The diluted share count rose 17.1%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Flotek Industries does
Flotek is a chemistry and data company that serves the oil and gas industry. It has two segments.
The Chemistry Technologies segment designs, makes, packages and sells specialty chemicals to energy producers, for use in drilling and well completion. The company says these products help customers lower costs and reduce their environmental impact. The Data Analytics segment sells measuring equipment and digital services that give near real-time readings for controlling processes in oil and gas, and in newer uses such as power generation.
In April 2025 Flotek bought mobile power generation equipment from ProFrac GDM, a subsidiary of ProFrac, a company that is also a customer. The deal covered twenty-two operating units and eight more under construction, which were all in service by December 31, 2025. Flotek then leased the equipment back to ProFrac GDM. Total consideration for these transactions was $107.5 million, which included offsetting part of a contract shortfall fee that ProFrac owed it.
Its biggest risks, as it describes them
- Swings in commodity prices that change how much its energy customers spend.
- Reliance on its agreements with ProFrac affiliates, which could hurt its finances and cash flows.
- Not being able to develop new products or set existing ones apart, which could cost it customers.
- Losing key customers, or key suppliers and raw materials.
- Increased competition that pushes down prices, and not having enough capital.
Income statement
From fiscal 2024 to 2025, earnings per share grew 147.1% a year and net income 190.5% a year, as new shares raised the share count by 17% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 12 | 12 | 6 | 4 | 6 |
| Debt incl. finance leases | 5 | 5 | 0 | 0 | 40 |
| Net debt (negative means net cash) | −7 | −8 | −6 | −4 | 35 |
| Net debt to EBITDA | — | — | −0.2x | −0.3x | 1.4x |
| Debt to equity | 0.2x | — | 0.0x | 0.0x | 0.4x |
| Interest coverage | −403.3x | −5.0x | 8.1x | 11.1x | 5.9x |
| Current ratio | 2.3x | 0.5x | 1.6x | 1.9x | 1.8x |
| Quick ratio | 1.8x | 0.4x | 1.3x | 1.6x | 1.6x |
Cash flow
Projections
Project Flotek Industries' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
What Flotek Industries says to expect
- Full year 2027: capital expenditures
The Company expects capital expenditures in 2027 to total between $15 million and $20 million.
Insider trades
Over the 12 months between November 14, 2025 and November 13, 2026, 1 insider bought $34.3 million of Flotek Industries shares on the open market, and 2 insiders sold $60.4 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | ProFrac GDM LLC10% owner | Sold | 2,306,806 | $26.01 | $60.0 million | Form 4 |
| Sep 11, 2026 | Matthew WilksDirector | Bought | 1,319,493 | $26.01 | $34.3 million | Form 4 |
| May 18, 2026 | James Bond ClementChief Financial Officer | Sold | 12,554 | $20.08 | $252,084 | Form 4 |
| Feb 24, 2026 | James Bond ClementChief Financial Officer | Sold | 6,299 | $16.02 | $100,910 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 5 of 9 | 6 of 9 | 5 of 9 |
| Rule of 40 | — | — | — |
| Altman Z'' | −2.65 | −1.69 | −0.95 |
| Accruals ratio | 22.3% | 4.3% | 11.9% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Fail | Pass | Pass |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Fail | Fail | Fail |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Pass | Pass | Fail |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 5 of 9 | 6 of 9 | 5 of 9 |
Compare
Put Flotek Industries side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Flotek Industries | FY25 | 26.9% | 9.8% | — | 18.1% | 1.4x | 5 | |
| Orion | FY25 | −3.8% | 1.5% | 3.0% | 1.3% | 8.1x | 3 | Compare |
| Ashland Global | FY25 | −13.7% | −42.5% | 2.0% | −17.5% | — | 5 | Compare |
| ASP Isotopes | FY25 | 475.5% | −251.2% | −198.9% | — | — | 3 | Compare |
| Cabot | FY25 | −7.0% | 16.7% | 10.5% | 15.9% | 1.1x | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 188 | 243 | 178 | 119 | 53 | 43 | 136 | 188 | 187 | 237 |
| Revenue growth | −43.7% | 29.1% | −26.9% | −32.9% | −55.5% | −18.6% | 214.5% | 38.2% | −0.6% | 26.9% |
| Gross profit | 91 | 28 | — | — | −29 | 3 | −7 | 24 | 39 | 60 |
| Research and development | 9 | 13 | 10 | 9 | 7 | 6 | 4 | 2 | 2 | 2 |
| Operating income | −17 | −10 | −70 | −76 | −144 | −32 | −35 | 23 | 12 | 23 |
| Net income | −49 | −27 | −70 | −34 | −136 | −30 | −42 | 25 | 10 | 30 |
| Diluted EPS (US$) | −5.28 | −2.82 | −7.26 | −3.30 | −12.00 | −2.52 | −3.41 | −0.10 | 0.34 | 0.84 |
| Diluted shares (millions) | 9 | 10 | 10 | 10 | 11 | 12 | 12 | 28 | 31 | 36 |
| Cash flow | ||||||||||
| Cash from operations | 2 | 12 | −21 | −4 | −48 | −26 | −45 | −11 | 3 | 7 |
| Capital expenditure | 13 | 4 | 4 | 2 | 1 | 0 | 0 | — | — | — |
| Free cash flow | −11 | 8 | −24 | −7 | −49 | −26 | −45 | — | — | — |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 8 | 0 | 0 | 0 | 26 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 11 | 11 | 7 | 4 | 3 | 4 | 3 | −0 | 1 | 2 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 5 | 5 | 3 | 101 | 39 | 12 | 12 | 6 | 4 | 6 |
| Debt incl. finance leases | 48 | 28 | 50 | 0 | 6 | 5 | 5 | 0 | 0 | 40 |
| Total assets | 383 | 330 | 286 | 231 | 86 | 50 | 165 | 158 | 171 | 220 |
| Total liabilities | 96 | 65 | 84 | 59 | 39 | 30 | 162 | 56 | 57 | 107 |
| Shareholders' equity | 287 | 265 | 202 | 172 | 47 | 20 | 3 | 102 | 114 | 113 |
| Margins and ratios | ||||||||||
| Gross margin | 48.2% | 11.5% | — | — | −54.0% | 7.5% | −4.9% | 12.9% | 21.1% | 25.2% |
| Operating margin | −9.0% | −4.2% | −39.3% | −63.3% | −270.3% | −72.7% | −26.0% | 12.3% | 6.5% | 9.8% |
| Net margin | −26.1% | −11.3% | −39.6% | −28.4% | −256.8% | −70.5% | −31.1% | 13.1% | 5.6% | 12.9% |
| Free cash flow margin | −5.8% | 3.4% | −13.7% | −5.8% | −92.7% | −59.8% | −33.1% | — | — | — |
| Rule of 40 (growth + FCF margin) | −49.6% | 32.5% | −40.6% | −38.7% | −148.2% | −78.4% | 181.4% | — | — | — |
| Return on capital | −4.0% | −2.6% | −20.5% | −37.1% | −260.1% | −178.3% | — | 50.5% | 11.2% | 18.1% |
| Return on equity | −16.9% | −9.9% | −30.1% | −18.1% | −124.5% | −90.6% | −371.3% | 47.3% | 9.7% | 26.9% |
| Return on assets | −12.5% | −7.7% | −22.9% | −13.1% | −86.1% | −44.7% | −39.3% | 15.3% | 6.4% | 15.6% |
| Net debt to EBITDA | — | — | — | — | — | — | — | −0.2x | −0.3x | 1.4x |